JPMORGAN CHASE & CO - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 17 filers reported holding TREVI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$58,827
-25.8%
26,985
-18.7%
0.00%
Q2 2023$79,28633,174
+1105700.0%
0.00%
Q3 2020$030.0%0.00%
Q2 2020$030.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,263,408$2,843,0000.32%
NEA Management Company, LLC 5,940,796$13,367,0000.17%
TPG Group Holdings (SBS) Advisors, Inc. 4,824,883$10,856,0000.08%
WealthTrust Axiom LLC 39,500$88,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 34,600$78,0000.00%
BlackRock Inc. 44,180$99,0000.00%
LPL Financial LLC 10,000$23,0000.00%
Alberta Investment Management Corp 25,000$56,0000.00%
Tower Research Capital LLC (TRC) 4,187$10,0000.00%
Renaissance Technologies 92,600$208,0000.00%
View complete list of TREVI THERAPEUTICS INC shareholders